HDAC2 and liver cancer: Next, to validate our observations in in vivo model, we prepared diethylnitrosamine (DEN)–induced liver cancer rat models and examined cell cycle molecules and HDAC2 expressions in hepatocellular carcinoma tissues (Fig. 5A).